Updated:
SpyGlass Pharma, Inc.
SpyGlass Pharma develops investigational ocular drug-delivery systems and completed its Advanced Vision Science acquisition in October 2026.
Overview
SpyGlass Pharma develops sustained drug-delivery systems for chronic eye conditions. Its investigational BIM-IOL system combines drug pads with an intraocular lens designed for use during cataract surgery. On October 1, 2026, SpyGlass completed the acquisition of Advanced Vision Science, its intraocular-lens supplier, from Santen. The transaction brought that lens business into the group; BIM-IOL remains investigational. Its reported principal executive office is in Irvine, CA (United States). For fiscal 2025, ended 2025-12-31, its originally reported results included a net loss of USD 39,869,000; cash used in operations of USD 32,701,000. At that year-end, it reported total assets of USD 115,866,000 and cash and cash equivalents of USD 96,358,000.
Company overview
- Legal name
- SpyGlass Pharma, Inc.
- Former names in filing history
- SpyGlassPharma, Inc. (2023-07-11 to 2025-06-05); SpyGlass Ophthalmics, Inc. (2019-06-05 to 2021-01-05)
- Classification
- Public company
- Industry (SIC)
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters
- Irvine, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001778922
- Website
- spyglasspharma.com
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2025USD | -$39.9M | $115.9M | $96.4M | -$32.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 424B4 | — | 424B4 | |
| S-1 | — | S-1 |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research SpyGlass Pharma, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.